In the past two years, findings from important clinical trials are shaping a new approach to treating different subgroups of patients with metastatic colorectal cancer (mCRC). Today, screening patients for biomarkers such as microsatellite instability status, BRAFV600E, HER2 and neurotrophic tyrosine receptor kinase (NTRK) is understood to be a fundamental ...

Hold the Date! On behalf of Colorectal Cancer Canada (CCC), you are cordially invited to attend the Patient Group Pathway Model to Accessing Cancer Clinical Trials and Real World Evidence Methodologies Conference with a special focus on precision medicine. Conference: October 21, 2020 (9:00 am - 4:00 pm) Location: THE ...

What is Lynch Syndrome? Lynch syndrome is a genetically inherited condition, also known as hereditary nonpolyposis colorectal cancer (HNPCC)¹. Lynch syndrome increases the risk of a number of cancers, including cancer of the colon, ovary and uterus, stomach, pancreas, urinary tract and prostate¹. Although there are many genetic syndromes which ...

Coronavirus has taken the world by storm since the beginning of 2020, and has impacted us all in many ways. However, the impact of the virus on cancer patients, their treatment and their quality of life has been significant. In April 2020, Colorectal Cancer Canada set out to investigate the ...

To ensure the health and safety of our participants, volunteers, staff and wonderful sponsors, we announced in March that all of Push For Your Tush 2020 5k /10k run/walks across Canada would go virtual. We are so proud to announce that we had 255 participants, 60 teams, over 1350 donations ...

It has been known for millennia that what we eat can be powerful medicine – or a slow poison. According to Ayurvedic medicine, the 5,000 year-old healing system originating in India, all good health starts with diet and digestion. Today, there is a growing body of evidence that shows how ...

The last few decades have seen important advances in colorectal cancer treatment. There are more options today for patients with colorectal cancer who historically may have had fewer effective treatments available to them, particularly those with advanced disease. One of the major highlights from the recent American Society of Clinical ...

In just a few months, coronavirus (COVID-19) has transformed our lives. Despite the innumerable challenges, COVID-19 has created an opportunity for the revision of healthcare approaches and norms, including how cancer care is practiced. As hospitals are increasingly forced to focus their resources on treating patients with COVID-19, fewer resources ...